MedTrace Logo

Default Options to Reduce Unnecessary Daily Imaging During Palliative Radiation

NCT03110692 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1188

Last updated 2019-12-09

Study results available
· View outcomes & findings →

Summary

The goal of this study is to reduce preference sensitive, unnecessary daily imaging during radiation treatment in which a pre-planned quality improvement default option for radiation treatment prescriptions will be introduced throughout the network of Penn Radiation Oncology.

Conditions

Interventions

BEHAVIORAL

Default initiation

A default prescription template will be introduced in the palliative setting in order to reduce unnecessary daily image guided radiation.

Sponsors & Collaborators

Principal Investigators

  • Justin Bekelman, MD · University of Pennsylvania

  • Mitesh Patel, MD, MBA, MS · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-10
Primary Completion
2017-10-09
Completion
2018-02-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03110692 on ClinicalTrials.gov